Peripheral Blood Stem Cell TransplantationTransplantation, AutologousHematopoietic Stem Cell TransplantationStem Cell TransplantationHematopoietic Stem Cell MobilizationTransplantation ConditioningTransplantation, HomologousCombined Modality TherapyMelphalanMultiple MyelomaHematologic NeoplasmsGranulocyte Colony-Stimulating FactorStem CellsAntigens, CD34LeukapheresisAntineoplastic Combined Chemotherapy ProtocolsTreatment OutcomeBlood Component RemovalCyclophosphamideHematopoietic Stem CellsMyeloablative AgonistsRemission InductionGraft vs Host DiseaseBusulfanRecurrenceLymphoma, Non-HodgkinBone Marrow TransplantationGraft SurvivalAmyloidosisEtoposideThiotepaAntineoplastic Agents, AlkylatingSalvage TherapyCarmustineHodgkin DiseaseVincristineDisease-Free SurvivalIfosfamideCytarabineCytophagocytosisRetrospective StudiesSurvival RateHematopoiesisTissue DonorsCord Blood Stem Cell TransplantationWhole-Body IrradiationTransplantation ChimeraSurvival AnalysisNeoplasmsTime FactorsDoxorubicinBone Marrow PurgingHistocompatibilityDexamethasoneImmunosuppressive AgentsHistocompatibility TestingInfectionEmbryonic Stem CellsThalidomidePrednisoneFollow-Up StudiesLeukemia, Myeloid, AcutePlatelet CountCytomegalovirus InfectionsCarboplatinLymphoma, T-CellBoronic AcidsAdult Stem CellsPyrazinesAntineoplastic AgentsLymphomaPOEMS SyndromeLeukemiaMesenchymal Stem Cell TransplantationFatal OutcomeProspective StudiesVidarabineTransplantation, IsogeneicRecombinant ProteinsFeasibility StudiesBlood Cell CountGraft vs Leukemia EffectPluripotent Stem CellsPrognosisMyelodysplastic SyndromesOpportunistic InfectionsBlood CellsBlood Transfusion, AutologousCell DifferentiationAnemia, AplasticImmunophenotypingStem Cell NicheLeukemia, Myelogenous, Chronic, BCR-ABL PositiveHematologic DiseasesT-LymphocytesBone MarrowFlow CytometryNeural Stem CellsPrecursor Cell Lymphoblastic Leukemia-LymphomaCells, Cultured